|

XTR006 Clinical Trials

1 actively recruiting trial

Also known as: Florquinitau, [18F]MK 6240

Pipeline

Phase 3: 1

Top Sponsors

  • Sinotau Pharmaceutical Group1

Indications

  • Neurofibrillary Tangle1
  • Alzheimer's Disease1
  • Alzheimer Disease1

Other1 trial

Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.